Highlights From AANEM 2023 Concerning Myasthenia Gravis.

Published Date: 28 Nov 2023

The ADAPT+ study of efgartigimod, disparities in diagnosis, and eculizumab use in pregnancy are among the important data on myasthenia gravis from AANEM 2023 that Dr. Nicholas Silvestri reviewed.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

How access to specialized cancer centers affects glioblastoma outcomes

2.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

3.

Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.

4.

U.S. Nurse Found Dead; Harvey Weinstein's Cancer; Creepy Source of Ear Pain

5.

Beyond What Is Visible in Myelofibrosis?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot